Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
TC-6987
print preview
bookmark
share with colleague
General Information
Company
Targacept Inc.
Description
Neuronal nicotinic receptor alpha 7 (CHRNA7) modulator
Molecular Target
Nicotinic acetylcholine receptor alpha 7 (CHRNA7)
Mechanism of Action
Nicotinic receptor modulator
Latest Stage of Development
Phase II
Indication
Inflammatory disease
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy